Import of AIDS drugs streamlined

    By Shan Juan (China Daily)
    Updated: 2007-12-03 07:48

    The top food and drug agency is streamlining approval procedures for importing drugs to treat the estimated 85,000 patients in the country suffering from full-blown AIDS.

    The move came after China released its HIV/AIDS prevalence and prevention assessment report for this year on Thursday, which stated that about 700,000 people in the country are living with AIDS and the HIV virus which causes the disease.

    Zhang Wei, director with the drug registration department of the State Food and Drug Administration (SFDA), said his administration has always attached great importance to importing AIDS drugs.

    "The approval work (for imported AIDS drugs) has never stopped," Zhang said.

    He said a streamlined approval method has been adopted for imports of drugs that show significant clinical effects in treating diseases such as AIDS and cancer.

    A regulation on drug approval was also amended in July making procedures more transparent and efficient, which could see certain procedures going faster in special cases.

    It costs 120 working days to register an AIDS drug compared with 150 for most others, Zhang said.

    Approval for the import of TDF, a key drug in the second line of anti-retroviral treatment also known as the cocktail therapy for AIDS, is currently under way and is expected to be completed in time, he said.

    The United States-based Gliead, the drug's developer, filed the required application in August, said Zhang.

    So far, only seven kinds of AIDS drugs mainly prescribed for first-line anti-retroviral treatment are available in China, with 37,497 AIDS patients reportedly getting free treatment with government aid.

    About 10 percent of patients on the first-line treatment, however, develop resistance after taking the drugs for one year and have to switch to the second-line drugs to survive, said Hao Yao, deputy director with the disease control department of the Health Ministry.

    To reduce the drug resistance also faced by AIDS patients in other countries, Hao strongly urged Chinese patients to stick to their treatment as many kinds of drugs in the second-line cocktail treatment such as TDF are still unavailable here and have to be imported from foreign countries.

    "We are aware of the pressing issues and are considering further measures and policies," Zhang said.

    Last week, the SFDA approved the import of Lopinavir/ritonavir, produced by the US-based Abbott Laboratories, which is also a crucial part of the second-line cocktail treatment.

    In another development, the Ministry of Health has launched a pilot scheme on second-line therapy in Henan, Anhui and Hubei provinces, said Hao.

    "This will be further expanded to the whole country," he said.



    Top China News  
    Today's Top News  
    Most Commented/Read Stories in 48 Hours
    国产品无码一区二区三区在线| 精品无码久久久久久久久久 | 无码精品日韩中文字幕| 久久无码国产专区精品| 亚洲熟妇无码八V在线播放 | 无码人妻丝袜在线视频| 亚洲精品97久久中文字幕无码| 亚洲V无码一区二区三区四区观看| 欧美中文字幕在线视频| 亚洲国产精品无码久久九九 | 无码精品国产VA在线观看DVD| 日韩中文在线视频| 在线观看免费无码视频| 久久精品国产亚洲AV无码麻豆| 无码人妻一区二区三区一| 暖暖免费在线中文日本| a中文字幕1区| 中文字幕av高清片| 国产激情无码一区二区三区| 无码GOGO大胆啪啪艺术| 亚洲精品中文字幕无码蜜桃| 欧美一级一区二区中文字幕| 色综合久久综合中文综合网| 99在线精品国自产拍中文字幕| 久久久久久av无码免费看大片| 欧洲无码一区二区三区在线观看| 伊人久久综合无码成人网| 免费看成人AA片无码视频吃奶| 无码人妻少妇久久中文字幕| 最近免费中文字幕高清大全 | 综合国产在线观看无码| 免费VA在线观看无码| 九九久久精品无码专区| av潮喷大喷水系列无码| 无码精品一区二区三区免费视频 | 久久久久成人精品无码中文字幕| 无码专区6080yy国产电影| 久久久久无码国产精品不卡| 精品人体无码一区二区三区| 亚洲日韩VA无码中文字幕| 中文字幕人妻无码系列第三区|